Vitamin ve Takviye İlaç Kullanımı
Özet
Vitaminler ve mineraller, serbest radikalleri ve diğer reaktif türleri nötralize ederek oksidatif hasara karşı koruma sağlayabilir ve kanser riskini azaltabilir. İnsanların vitamin ve minerallere düzenli maruziyeti diyet yoluyla olur. 2020-2025 ABD Beslenme Kılavuzları, vitamin ve minerallere ek olarak, hiç veya çok az eklenmiş şeker, doymuş yağ ve sodyum içeren diğer sağlık geliştirici bileşenler içerdiklerinden, besin gereksinimlerinin öncelikle besin açısından yoğun yiyecek ve
içeceklerden karşılanmasını önermektedir. Benzer şekilde, Beslenme ve Diyetetik Akademisi (2018); Dünya Kanser Araştırma Fonu ve Amerikan Kanser Araştırma Enstitüsü (2018) ve Amerikan Kalp Derneği (2014) dahil olmak üzere diğer kuruluşların, sağlıklı yetişkinlerin besin ihtiyaçlarını öncelikle sağlıklı bir diyetle karşılamalarını ve vitaminlerin kardiyovasküler hastalık veya kanser önleme için kullanılmaması gerektiğini öneren kılavuzları vardır. Kanada Kanser Derneği ise D vitamini dışında beslenme ihtiyaçlarının sağlıklı bir diyetle karşılanmasını önermektedir. D vitamini için ise bireylerin sonbahar ve kış aylarında D vitamininin kanser önlemedeki olası rolünü göz önünde bulundurarak doktorlarıyla takviye alım hakkında görüşmelerini önermektedir.
Vitamins and minerals can protect against oxidative damage and reduce the risk of cancer by neutralizing free radicals and other reactive species. Regular human exposure to vitamins and minerals comes from the diet. The 2020–2025 U.S. Dietary Guidelines recommend that, in addition to vitamins and minerals, nutrient needs be met primarily through nutrient-dense foods and beverages, as they contain other health-promoting ingredients that contain little or no added sugar, saturated fat, and sodium. Similarly, other organizations, including the Academy of Nutrition and Dietetics (2018); the World Cancer Research Fund and the American Institute for Cancer Research (2018) and the American Heart Association (2014), have guidelines that recommend that healthy adults primarily meet their nutrient needs through a healthy diet and that vitamins should not be used for cardiovascular disease or cancer prevention. The Canadian Cancer Society recommends that, with the exception of vitamin D, nutrient needs be met through a healthy diet. For vitamin D, it is recommended that individuals talk to their doctors about taking supplements during the fall and winter months, considering the possible role of vitamin D in cancer prevention.
Referanslar
Dattola A, Silvestri M, Bennardo L, Passante M, Scali E, Patruno C, et al. Role of Vitamins in Skin Health: a Systematic Review. Curr Nutr Rep. 2020 Sep;9(3):226-35.
Mendes MM, Charlton K, Thakur S, Ribeiro H, Lanham-New SA. Future perspectives in addressing the global issue of vitamin D deficiency. Proc Nutr Soc. 2020 May;79(2):246-51.
Zerwekh JE. Blood biomarkers of vitamin D status. The American Journal of Clinical Nutrition. 2008 Apr;87(4):1087S-1091S.
Kanellopoulou A, Riza E, Samoli E, Benetou V. Dietary Supplement Use after Cancer Diagnosis in Relation to Total Mortality, Cancer Mortality and Recurrence: A Systematic Review and Meta-Analysis. Nutrition and Cancer. 2021 Jan 2;73(1):16-30.
Pouchieu C, Fassier P, Druesne-Pecollo N, Zelek L, Bachmann P, Touillaud M, et al. Dietary supplement use among cancer survivors of the NutriNet-Santé cohort study. Br J Nutr. 2015 Apr 28;113(8):1319-29.
Keum N, Lee D, Greenwood D, Manson J, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Annals of Oncology. 2019 May;30(5):733-43.
Keum N, Chen Q, Lee DH, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality by daily vs. infrequent large-bolus dosing strategies: a meta-analysis of randomised controlled trials. Br J Cancer. 2022 Sep 1;127(5):872-8.
Freedman DM, Looker AC, Abnet CC, Linet MS, Graubard BI. Serum 25-Hydroxyvitamin D and Cancer Mortality in the NHANES III Study (1988–2006). Cancer Research. 2010 Nov 1;70(21):8587-97.
Giustina A, Bilezikian JP, Adler RA, Banfi G, Bikle DD, Binkley NC, et al. Consensus Statement on Vitamin D Status Assessment and Supplementation: Whys, Whens, and Hows. Endocrine Reviews. 2024 Sep 12;45(5):625-54.
Burton GW, Joyce A, Ingold KU. Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?. Archives of Biochemistry and Biophysics. 1983 Feb;221(1):281-90.
Miller ER, Pastor-Barriuso R, Dalal D, Riemersma RA, Appel LJ, Guallar E. Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality. Ann Intern Med. 2005 Jan 4;142(1):37.
Kushi LH, Fee RM, Sellers TA, Zheng W, Folsom AR. Intake of Vitamins A, C, and E and Postmenopausal Breast Cancer: The Iowa Women's Health Study. American Journal of Epidemiology. 1996 Jul 15;144(2):165-74.
Hunter DJ, Manson JE, Colditz GA, Stampfer MJ, Rosner B, Hennekens CH, et al. A Prospective Study of the Intake of Vitamins C, E, and A and the Risk of Breast Cancer. N Engl J Med. 1993 Jul 22;329(4):234-40.
Zhang S, Hunter DJ, Forman MR, Rosner BA, Speizer FE, Colditz GA, et al. Dietary Carotenoids and Vitamins A, C, and E and Risk of Breast Cancer. JNCI Journal of the National Cancer Institute. 1999 Mar 17;91(6):547-56.
Chan JM, Stampfer MJ, Ma J, Rimm EB, Willett WC, Giovannucci EL. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev. 1999 Oct;8(10):893-9.
Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, et al. Supplemental and Dietary Vitamin E, β-Carotene, and Vitamin C Intakes and Prostate Cancer Risk. JNCI: Journal of the National Cancer Institute. 2006 Feb 15;98(4):245-54.
Woodson K, Tangrea JA, Barrett MJ, Virtamo J, Taylor PR, Albanes D. Serum -Tocopherol and Subsequent Risk of Lung Cancer Among Male Smokers. JNCI Journal of the National Cancer Institute. 1999 Oct 20;91(20):1738-43.
Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Van Denburgh M, et al. Vitamins C and E and Beta Carotene Supplementation and Cancer Risk: A Randomized Controlled Trial. JNCI Journal of the National Cancer Institute. 2009 Jan 7;101(1):14-23.
Greenberg ER, Baron JA, Tosteson TD, Freeman DH, Beck GJ, Bond JH, et al. A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma. N Engl J Med. 1994 Jul 21;331(3):141-7.
Gaziano JM, Glynn RJ, Christen WG, Kurth T, Belanger C, MacFadyen J, et al. Vitamins E and C in the Prevention of Prostate and Total Cancer in Men. JAMA. 2009 Jan 7;301(1):52.
Lee I, Cook NR, Gaziano JM, Gordon D, Ridker PM, Manson JE, et al. Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer. JAMA. 2005 Jul 6;294(1):56.
Sluyter JD, Manson JE, Scragg R. Vitamin D and Clinical Cancer Outcomes: A Review of Meta-Analyses. JBMR Plus. 2021 Jan;5(1):e10420.
Lippman SM, Klein EA, Goodman PJ, Lucia MS, Thompson IM, Ford LG, et al. Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers. JAMA. 2009 Jan 7;301(1):39.
Virtamo J, Taylor PR, Kontto J, Männistö S, Utriainen M, Weinstein SJ, et al. Effects of α‐tocopherol and β‐carotene supplementation on cancer incidence and mortality: 18‐Year postintervention follow‐up of the Alpha‐Tocopherol, Beta‐Carotene Cancer Prevention Study. Intl Journal of Cancer. 2014 Jul;135(1):178-85.
Klein EA, Thompson IM, Tangen CM, Crowley JJ, Lucia MS, Goodman PJ, et al. Vitamin E and the Risk of Prostate Cancer. JAMA. 2011 Oct 12;306(14):1549.
Sesso HD, Rist PM, Aragaki AK, Rautiainen S, Johnson LG, Friedenberg G, et al. Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. The American Journal of Clinical Nutrition. 2022 Jun;115(6):1501-10.
The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med. 1994 Apr 14;330(15):1029-35.
Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. Effects of a Combination of Beta Carotene and Vitamin A on Lung Cancer and Cardiovascular Disease. N Engl J Med. 1996 May 2;334(18):1150-5.
Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA. 2003 Jul 23;290(4):476-85.
Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. Lack of Effect of Long-Term Supplementation with Beta Carotene on the Incidence of Malignant Neoplasms and Cardiovascular Disease. N Engl J Med. 1996 May 2;334(18):1145-9.
Lee I, Cook NR, Manson JE, Buring JE, Hennekens CH. β-Carotene Supplementation and Incidence of Cancer and Cardiovascular Disease: the Women's Health Study. JNCI: Journal of the National Cancer Institute. 1999 Dec 15;91(24):2102-6.
Tamimi RM. Plasma Carotenoids, Retinol, and Tocopherols and Risk of Breast Cancer. American Journal of Epidemiology. 2005 Jan 15;161(2):153-60.
Heinonen OP, Koss L, Albanes D, Taylor PR, Hartman AM, Edwards BK, et al. Prostate Cancer and Supplementation With α-Tocopherol and β-Carotene: Incidence and Mortality in a Controlled Trial. JNCI: Journal of the National Cancer Institute. 1998 Mar 18;90(6):440-6.
O’Connor EA, Evans CV, Ivlev I, Rushkin MC, Thomas RG, Martin A, et al. Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer. JAMA. 2022 Jun 21;327(23):2334.
Omenn GS, Beresford SAA, Motulsky AG. Preventing Coronary Heart Disease. Circulation. 1998 Feb 10;97(5):421-4.
Mocellin S, Briarava M, Pilati P. Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis. JNCI J Natl Cancer Inst. 2017 Mar;109(3):djw230.
Oakley GP. Eat RightandTake a Multivitamin. N Engl J Med. 1998 Apr 9;338(15):1060-1.
Giovannucci E. Multivitamin Use, Folate, and Colon Cancer in Women in the Nurses' Health Study. Ann Intern Med. 1998 Oct 1;129(7):517.
Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, Willett WC. Alcohol, Low-Methionine-Low-Folate Diets, and Risk of Colon Cancer in Men. JNCI Journal of the National Cancer Institute. 1995 Feb 15;87(4):265-73.
Lewis SJ, Harbord RM, Harris R, Smith GD. Meta-analyses of Observational and Genetic Association Studies of Folate Intakes or Levels and Breast Cancer Risk. JNCI: Journal of the National Cancer Institute. 2006 Nov 15;98(22):1607-22.
Larsson SC, Giovannucci E, Wolk A. Folate and Risk of Breast Cancer: A Meta-analysis. JNCI: Journal of the National Cancer Institute. 2007 Jan 3;99(1):64-76.
Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic Acid for the Prevention of Colorectal Adenomas. JAMA. 2007 Jun 6;297(21):2351.
Logan RF, Grainge MJ, Shepherd VC, Armitage NC, Muir KR. Aspirin and Folic Acid for the Prevention of Recurrent Colorectal Adenomas. Gastroenterology. 2008 Jan;134(1):29-38.
Ebbing M. Cancer Incidence and Mortality After Treatment With Folic Acid and Vitamin B12. JAMA. 2009 Nov 18;302(19):2119.
Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE. Effect of Combined Folic Acid, Vitamin B6, and Vitamin B12on Cancer Risk in Women. JAMA. 2008 Nov 5;300(17):2012.
Green R, Allen LH, Bjørke-Monsen AL, Brito A, Guéant JL, Miller JW, et al. Vitamin B12 deficiency. Nat Rev Dis Primers. 2017 Jun 29;3:17040.
Allen LH, Miller JW, de Groot L, Rosenberg IH, Smith AD, Refsum H, et al. Biomarkers of Nutrition for Development (BOND): Vitamin B-12 Review. J Nutr. 2018 Dec 1;148(suppl_4):1995S-2027S.
Brasky TM, Ray RM, Navarro SL, Schenk JM, Newton AM, Neuhouser ML. Supplemental one-carbon metabolism related B vitamins and lung cancer risk in the Women's Health Initiative. Int J Cancer. 2020 Sep 1;147(5):1374-84.
Wang L, Sesso HD, Glynn RJ, Christen WG, Bubes V, Manson JE, et al. Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians’ Health Study II randomized trial , , ,. The American Journal of Clinical Nutrition. 2014 Sep;100(3):915-23.
Clark LC. The epidemiology of selenium and cancer. Fed Proc. 1985 Jun;44(9):2584-9.
Gerald F. C. Current Evidence and Research Needs to Support a Health Claim for Selenium and Cancer Prevention. The Journal of Nutrition. 2005 Feb;135(2):343-7.
Steevens J, van den Brandt PA, Goldbohm RA, Schouten LJ. Selenium Status and the Risk of Esophageal and Gastric Cancer Subtypes: The Netherlands Cohort Study. Gastroenterology. 2010 May;138(5):1704-13.
Vinceti M, Dennert G, Crespi CM, Zwahlen M, Brinkman M, Zeegers MP, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2014 Mar 30;2014(3):CD005195.
Vinceti M, Filippini T, Del Giovane C, Dennert G, Zwahlen M, Brinkman M, et al. Selenium for preventing cancer. Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195.
Kristal AR, Darke AK, Morris JS, Tangen CM, Goodman PJ, Thompson IM, et al. Baseline selenium status and effects of selenium and vitamin e supplementation on prostate cancer risk. J Natl Cancer Inst. 2014 Mar;106(3):djt456.
Zeegers MP, Goldbohm RA, Bode P, van den Brandt PA. Prediagnostic toenail selenium and risk of bladder cancer. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1292-7.
KELLEN E, ZEEGERS M, BUNTINX F. Selenium is inversely associated with bladder cancer risk: A report from the Belgian case–control study on bladder cancer. Int J of Urology. 2006 Sep;13(9):1180-4.
Yalçin O, Karataş F, Erulaş F, Özdemir E. The levels of glutathione peroxidase, vitamin A, E, C and lipid peroxidation in patients with transitional cell carcinoma of the bladder. BJU International. 2004 Apr;93(6):863-6.
Lotan Y, Goodman PJ, Youssef RF, Svatek RS, Shariat SF, Tangen CM, et al. Evaluation of Vitamin E and Selenium Supplementation for the Prevention of Bladder Cancer in SWOG Coordinated SELECT. Journal of Urology. 2012 Jun;187(6):2005-10.
Pietinen P, Malila N, Virtanen M, Hartman TJ, Tangrea JA, Albanes D, et al. None. Cancer Causes and Control. 1999;10(5):387-96.
Garland C, Barrett-Connor E, Rossof A, Shekelle R, Criqui M, Paul O. DIETARY VITAMIN D AND CALCIUM AND RISK OF COLORECTAL CANCER: A 19-YEAR PROSPECTIVE STUDY IN MEN. The Lancet. 1985 Feb;325(8424):307-9.
Wu K. Calcium Intake and Risk of Colon Cancer in Women and Men. CancerSpectrum Knowledge Environment. 2002 Mar 20;94(6):437-46.
Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, et al. Calcium plus Vitamin D Supplementation and the Risk of Colorectal Cancer. N Engl J Med. 2006 Feb 16;354(7):684-96.
Chan JM, Giovannucci EL. Diet: Dairy Products, Calcium, and Vitamin D and Risk of Prostate Cancer. Epidemiologic Reviews. 2001 Jan 1;23(1):87-92.
Giovannucci E, Rimm EB, Wolk A, Ascherio A, Stampfer MJ, Colditz GA, et al. Calcium and fructose intake in relation to risk of prostate cancer. Cancer Res. 1998 Feb 1;58(3):442-7.
Chan JM, Stampfer MJ, Ma J, Gann PH, Gaziano JM, Giovannucci EL. Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study. The American Journal of Clinical Nutrition. 2001 Oct;74(4):549-54.
Rodriguez C, McCullough ML, Mondul AM, Jacobs EJ, Fakhrabadi-Shokoohi D, Giovannucci EL, et al. Calcium, dairy products, and risk of prostate cancer in a prospective cohort of United States men. Cancer Epidemiol Biomarkers Prev. 2003 Jul;12(7):597-603.
Schuurman AG, Brandt PAvd, Dorant E, Goldbohm RA. Animal products, calcium and protein and prostate cancer risk in the Netherlands Cohort Study. Br J Cancer. 1999 Jun;80(7):1107-13.
Chan JM, Pietinen P, Virtanen M, Malila N, Tangrea J, Albanes D, et al. None. Cancer Causes and Control. 2000;11(9):859-67.
Olechnowicz J, Tinkov A, Skalny A, Suliburska J. Zinc status is associated with inflammation, oxidative stress, lipid, and glucose metabolism. J Physiol Sci. 2018 Jan;68(1):19-31.
Shankar AH, Prasad AS. Zinc and immune function: the biological basis of altered resistance to infection. The American Journal of Clinical Nutrition. 1998 Aug;68(2):447S-463S.
Prasad AS. Zinc and immunity. Mol Cell Biochem. 1998 Nov;188(1-2):63-9.
Prasad AS, Meftah S, Abdallah J, Kaplan J, Brewer GJ, Bach JF, et al. Serum thymulin in human zinc deficiency.. J Clin Invest. 1988 Oct 1;82(4):1202-10.
Ribeiro SMdF, Braga CBM, Peria FM, Martinez EZ, Rocha JJRd, Cunha SFC. Effects of zinc supplementation on fatigue and quality of life in patients with colorectal cancer. Einstein (São Paulo). 2017 Mar;15(1):24-8.
Huang W, Hsu H, Yang T, Lu C, Pan Y, Wu C, et al. Zinc supplementation decreased incidence of grade ≥2 hand-foot skin reaction induced by regorafenib: A phase II randomized clinical trial. Journal of the American Academy of Dermatology. 2024 Feb;90(2):368-9.
Leitzmann MF, Stampfer MJ, Wu K, Colditz GA, Willett WC, Giovannucci EL. Zinc Supplement Use and Risk of Prostate Cancer. JNCI Journal of the National Cancer Institute. 2003 Jul 2;95(13):1004-7.
Zhang Y, Coogan P, Palmer JR, Strom BL, Rosenberg L. Vitamin and mineral use and risk of prostate cancer: the case–control surveillance study. Cancer Causes Control. 2009 Jul;20(5):691-8.
Price SA, Tisdale MJ. Mechanism of inhibition of a tumor lipid-mobilizing factor by eicosapentaenoic acid. Cancer Res. 1998 Nov 1;58(21):4827-31.
Wigmore SJ, Fearon KCH, Maingay JP, Ross JA. Down-Regulation of the Acute-Phase Response in Patients with Pancreatic Cancer Cachexia Receiving Oral Eicosapentaenoic Acid is Mediated via Suppression of Interleukin-6. Clinical Science. 1997 Feb 1;92(2):215-21.
MacLean CH, Newberry SJ, Mojica WA, Khanna P, Issa AM, Suttorp MJ, et al. Effects of Omega-3 Fatty Acids on Cancer Risk. JAMA. 2006 Jan 25;295(4):403.
Touvier M. B Vitamin and/or ω-3 Fatty Acid Supplementation and Cancer. Arch Intern Med. 2012 Apr 9;172(7):540.
de Aguiar Pastore Silva J, Emilia de Souza Fabre M, Waitzberg DL. Omega-3 supplements for patients in chemotherapy and/or radiotherapy: A systematic review. Clinical Nutrition. 2015 Jun;34(3):359-66.
